ALK/ROS1 rearrangements: A real hallmark for thromboembolic events in cancer patients?

被引：6
|
作者：
Nichetti, Federico [1 ]
Lo Russo, Giuseppe [1 ]
Prelaj, Arsela [1 ]
Provenzano, Leonardo [1 ]
de Braud, Filippo [1 ,2 ]
Cabiddu, Mary [3 ]
Garassino, Marina Chiara [1 ]
Petrelli, Fausto [3 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Via Venezian 1, I-20133 Milan, Italy
[2] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy
[3] ASST Bergamo Ovest, Med Oncol Unit, I-24047 Treviglio, BG, Italy
来源：
THROMBOSIS RESEARCH | 2020年 / 194卷
关键词：
Non-Small-Cell Lung Cancer; Thromboembolic events; Thrombosis; ALK; ROS-1; Tyrosine kinase inhibitors; VENOUS THROMBOEMBOLISM;
D O I：
10.1016/j.thromres.2020.06.041
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：176 / 177
页数：2
相关论文
共 50 条
  • [31] Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers
    Yoshida, Akihiko
    Tsuta, Koji
    Wakai, Susumu
    Arai, Yasuhito
    Asamura, Hisao
    Shibata, Tatsuhiro
    Furuta, Koh
    Kohno, Takashi
    Kushima, Ryoji
    MODERN PATHOLOGY, 2014, 27 (05) : 711 - 720
  • [32] Asbestos-related lung cancers are rarely associated with ALK, ROS1 and RET rearrangements
    Uguen, Marie
    Dewitte, Jean-Dominique
    Lodde, Brice
    Marcorelles, Pascale
    Uguen, Arnaud
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (03)
  • [33] ALK and ROS1 Testing on Lung Cancer Cytologic Samples: Perspectives
    Pisapia, Pasquale
    Lozano, Maria D.
    Vigliar, Elena
    Bellevicine, Claudio
    Pepe, Francesco
    Malapelle, Umberto
    Troncone, Giancarlo
    CANCER CYTOPATHOLOGY, 2017, 125 (11) : 817 - 830
  • [34] New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1)
    Russo, Alessandro
    Lopes, Ana Rita
    McCusker, Michael G.
    Garrigues, Sandra Gimenez
    Ricciardi, Giuseppina R.
    Arensmeyer, Katherine E.
    Scilla, Katherine A.
    Mehra, Ranee
    Rolfo, Christian
    CURRENT ONCOLOGY REPORTS, 2020, 22 (05)
  • [35] ALK and ROS1 as a joint target for the treatment of lung cancer: a review
    Puig de la Bellacasa, Raimon
    Karachaliou, Niki
    Estrada-Tejedor, Roger
    Teixido, Jordi
    Costa, Carlota
    Borrell, Jose I.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (02) : 72 - 86
  • [36] New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1)
    Alessandro Russo
    Ana Rita Lopes
    Michael G. McCusker
    Sandra Gimenez Garrigues
    Giuseppina R. Ricciardi
    Katherine E. Arensmeyer
    Katherine A. Scilla
    Ranee Mehra
    Christian Rolfo
    Current Oncology Reports, 2020, 22
  • [37] Evaluation of a Novel ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in NSCLC Patients
    Conde, E.
    Hernandez, S.
    Martinez, R.
    De Castro, J.
    Collazo-Lorduy, A.
    Jimenez, B.
    Muriel, A.
    Mate, J. L.
    Moran, T.
    Aranda, I.
    Massuti, B.
    Rojo, F.
    Domine, M.
    Sansano, I.
    Garcia, F.
    Felip, E.
    Mancheno, N.
    Juan, O.
    Sanz, J.
    Gonzalez-Larriba, J. L.
    Atienza-Cuevas, L.
    Arriola-Arellano, E.
    Abdulkader, I.
    Garcia, J.
    Camacho, C.
    Rodriguez-Abreu, D.
    Teixido, C.
    Reguart, N.
    Gonzalez-Pineiro, A.
    Lazaro-Quintela, M.
    Lozano, M. D.
    Gurpide, A.
    Gomez-Roman, J.
    Lopez-Brea, M.
    Pijuan, L.
    Salido, M.
    Arriola, E.
    Company, A.
    Insa, A.
    Esteban, I.
    Saiz, M.
    Azkona, E.
    Alvarez, R.
    Artal, A.
    Enguita, A. B.
    Benito, A.
    Paz-Ares, L.
    Garrido, P.
    Lopez-Rios, F.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S553 - S554
  • [38] The Frequency and Clinical Implication of ALK, ROS1, RET and NTRK1 Gene Rearrangements in Adenosquamous Lung Carcinoma Patients
    Shi, X.
    Wu, S.
    Duan, H.
    Liu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2274 - S2274
  • [39] Effect of Asbestos Exposure on the Frequency of EGFR Mutations and ALK/ROS1 Rearrangements in Patients With Lung Adenocarcinoma A Multicentric Study
    Yilmaz, Senay
    Demirci, Nilgun Yilmaz
    Metintas, Selma
    Zamani, Adil
    Karadag, Mehmet
    Guclu, Ozge A.
    Kabalak, Pinar Akin
    Yilmaz, Ulku
    Ak, Guntulu
    Kizilgoz, Derya
    Ozturk, Akin
    Yilmaz, Ufuk
    Batum, Ozgur
    Kavas, Murat
    Serifoglu, Irem
    Unsal, Meftun
    Komurcuoglu, Berna E.
    Cengiz, Tuba Inal
    Ulubay, Gaye
    Ozdemirel, Tugce S.
    Ozyurek, Berna A.
    Kavurgaci, Suna
    Alizoroglu, Dursun
    Celik, Pinar
    Erdogan, Yurdanur
    In, Erdal
    Aksoy, Asude
    Altin, Sedat
    Gunluoglu, Gulsah
    Metintas, Muzaffer
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2021, 63 (03) : 238 - 243
  • [40] Clinicopathological characteristics and survival of ALK, ROS1 and RET rearrangements in non-adenocarcinoma non-small cell lung cancer patients
    Song, Zhengbo
    Yu, Xinmin
    Zhang, Yiping
    CANCER BIOLOGY & THERAPY, 2017, 18 (11) : 883 - 887
12345